InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.00%
)
US TECH 100
19,445.60
(
-0.17%
)
Dow Jones
39,331.85
(
0.00%
)
Brent Oil
86.24
(
-0.24%
)
Bitcoin
60,156.32
(
-3.02%
)
Post# of 4856
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Seel

Send PM Follow Ignore
Followers 74
Posts 1863
Boards Moderated 0
Alias Born 04/30/2011

Seel

Re: garywoodruff post# 4012

Wednesday, 08/19/2015 7:45:54 PM

Wednesday, August 19, 2015 7:45:54 PM

Post# of 4856
Can't compare gary. Two completely different technologies. Both high risk - but imo stem cell investing is the highest risk area in an already risky biotech sector. AVXL still very early - will have cool downs in the future. CUR could skyrocket if investors like what they read when full publication of recent ALS study done - or - CUR could absolutely crash if they don't like the published info. Good luck with whatever you choose.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up